FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alessandro Zuddas

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Living Beings

Geographic Areas

Italy

Co-author Network

Publications

TOP 3
Edmund J S Sonuga-Barke; Jim Stevenson; Saskia van der Oord; Ian C K Wong; Alessandro Zuddas; Tobias Banaschewski; Daniel Brandeis; Jan Buitelaar; David Coghill; Samuele Cortese; David Daley; Marina Danckaerts; Ralf W Dittmann; Manfred Döpfner; Maite Ferrin; Chris Hollis; Martin Holtmann; Eric Konofal; Michel Lecendreux; Joseph Sergeant; Emily Simonoff
Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments.
Carlo Cianchetti; Grazia Campus; Valeria Carta; Maria Giuseppina Ledda; Roberta Littarru; Andrea Pittau; Alessandro Zuddas; Giuseppina Sannio Fancello
Child and Adolescent Behavior Inventory (CABI): A New Instrument for Epidemiological Studies and Pre-Clinical Evaluation.
Romano Arcieri; Maurizio Bonati; Flavia Chiarotti; Elena A P Germinario; Gabriele Masi; Pietro Panei; Stefano Vella; Alessandro Zuddas
Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alessandro Zuddas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Edmund J S Sonuga-Barke; Jim Stevenson; Saskia van der Oord; Ian C K Wong; Alessandro Zuddas; Tobias Banaschewski; Daniel Brandeis; Jan Buitelaar; David Coghill; Samuele Cortese; David Daley; Marina Danckaerts; Ralf W Dittmann; Manfred Döpfner; Maite Ferrin; Chris Hollis; Martin Holtmann; Eric Konofal; Michel Lecendreux; Joseph Sergeant; Emily Simonoff
Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments.
The American journal of psychiatry 2013;170(3):275-89.
2013: Carlo Cianchetti; Grazia Campus; Valeria Carta; Maria Giuseppina Ledda; Roberta Littarru; Andrea Pittau; Alessandro Zuddas; Giuseppina Sannio Fancello
Child and Adolescent Behavior Inventory (CABI): A New Instrument for Epidemiological Studies and Pre-Clinical Evaluation.
Clinical practice and epidemiology in mental health : CP & EMH 2013;9():51-61.
2012: Romano Arcieri; Maurizio Bonati; Flavia Chiarotti; Elena A P Germinario; Gabriele Masi; Pietro Panei; Stefano Vella; Alessandro Zuddas
Cardiovascular measures in children and adolescents with attention-deficit/hyperactivity disorder who are new users of methylphenidate and atomoxetine.
Journal of child and adolescent psychopharmacology 2012;22(6):423-431.
2012: Alessandro Zuddas
A crucial role for basic emotion awareness in the development of emotion regulation?
European child & adolescent psychiatry 2012;21(6):297-9.
2011: Alessandro Zuddas; Roberta Zanni; Tatiana Usala
Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2011;21(8):600-20.
2010: Marina Danckaerts; Edmund J S Sonuga-Barke; Tobias Banaschewski; Jan K Buitelaar; Manfred Döpfner; Chris Hollis; Paramala Santosh; Aribert Rothenberger; Joseph Sergeant; Hans-Christoph Steinhausen; Eric Taylor; Alessandro Zuddas; David Coghill
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review.
European child & adolescent psychiatry 2010;19(2):83-105.
2009: Paola Atzori; Tatiana Usala; Sara Carucci; Fabrice Danjou; Alessandro Zuddas
Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study.
Journal of child and adolescent psychopharmacology 2009;19(6):673-81.
2009: Tobias Banaschewski; Jan Buitelaar; David R Coghill; Joseph A Sergeant; Edmund Sonuga-Barke; Alessandro Zuddas; Eric Taylor
The MTA at 8.
Journal of the American Academy of Child and Adolescent Psychiatry 2009;48(11):1120-1; author reply 1123-4.
2009: Grazia Dell'Agnello; Dino Maschietto; Carmela Bravaccio; Filippo Calamoneri; Gabriele Masi; Paolo Curatolo; Dante Besana; Francesca Mancini; Andrea Rossi; Lynne Poole; Rodrigo Escobar; Alessandro Zuddas
Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(11):822-34.
2009: Grazia Dell'Agnello; Alessandro Zuddas; Gabriele Masi; Paolo Curatolo; Dante Besana; Andrea Rossi
Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions.
CNS drugs 2009;23(9):739-53.
2009: Benedetto Vitiello; Christoph Correll; Barbara van Zwieten-Boot; Alessandro Zuddas; Mara Parellada; Celso Arango
Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(9):629-35.
2009: Maria Giuseppina Ledda; Anna Lisa Fratta; Manuela Pintor; Alessandro Zuddas; Carlo Cianchetti
Early-onset psychoses: comparison of clinical features and adult outcome in 3 diagnostic groups.
Child psychiatry and human development 2009;40(3):421-37.
2009: Alessandra Frigerio; Paola Rucci; Robert Goodman; Massimo Ammaniti; Ombretta Carlet; Pina Cavolina; Giovanni de Girolamo; Carlo Lenti; Loredana Lucarelli; Elisa Mani; Andrea Martinuzzi; nadia micali; Annarita Milone; Pierluigi Morosini; Filippo Muratori; Franco Nardocci; Valentina Pastore; Gabriella Polidori; Andrea Tullini; Laura Vanzin; Laura Villa; Mauro Walder; Alessandro Zuddas; Massimo Molteni
Prevalence and correlates of mental disorders among adolescents in Italy: the PrISMA study.
European child & adolescent psychiatry 2009;18(4):217-26.
2008: Gian Marco Marzocchi; Jaap Oosterlaan; Alessandro Zuddas; Pina Cavolina; Hilde Geurts; Debora Redigolo; Claudio Vio; Joseph A Sergeant
Contrasting deficits on executive functions between ADHD and reading disabled children.
Journal of child psychology and psychiatry, and allied disciplines 2008;49(5):543-52.
2008: Tobias Banaschewski; David Coghill; Paramala Santosh; Alessandro Zuddas; Philip Asherson; Jan Buitelaar; Marina Danckaerts; Manfred Döpfner; Stephen Faraone; Aribert Rothenberger; Joseph Sergeant; Hans-Christoph Steinhausen; Edmund J S Sonuga-Barke; Eric Taylor
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guidelines. Part 2: a quantitative evaluation of long-acting medications].
Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 2008;36(2):97-106; quiz 106-7.
2008: Tobias Banaschewski; David Coghill; Paramala Santosh; Alessandro Zuddas; Philip Asherson; Jan Buitelaar; Marina Danckaerts; Manfred Döpfner; Stephen Faraone; Aribert Rothenberger; Joseph Sergeant; Hans-Christoph Steinhausen; Edmund J S Sonuga-Barke; Eric Taylor
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guideline. Part 1: overview and recommendations].
Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 2008;36(2):81-94; quiz 94-5.
2008: Tatiana Usala; Antonio Clavenna; Alessandro Zuddas; Maurizio Bonati
Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(1):62-73.
2007: Jan K Buitelaar; David Michelson; Marina Danckaerts; Christopher Gillberg; Thomas J Spencer; Alessandro Zuddas; Douglas E Faries; Shuyu Zhang; Joseph Biederman
A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year.
Biological psychiatry 2007;61(5):694-9.
2006: Tobias Banaschewski; David Coghill; Paramala Santosh; Alessandro Zuddas; Philip Asherson; Jan K Buitelaar; Marina Danckaerts; Manfred Döpfner; Stephen Faraone; Aribert Rothenberger; Joseph Sergeant; Hans-Christoph Steinhausen; Edmund J S Sonuga-Barke; Eric Taylor
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline.
European child & adolescent psychiatry 2006;15(8):476-95.
2006: Alessandro Zuddas; Gian Marco Marzocchi; Jaap Oosterlaan; Pina Cavolina; Bernadette Ancilletta; Joseph Sergeant
Factor structure and cultural factors of disruptive behaviour disorders symptoms in Italian children.
European psychiatry : the journal of the Association of European Psychiatrists 2006;21(6):410-8.
2006: Daniele Mugnaini; Gabriele Masi; Paola Brovedani; Chiara Chelazzi; Marzenka Matas; Caterina Romagnoli; Alessandro Zuddas
Teacher reports of ADHD symptoms in Italian children at the end of first grade.
European psychiatry : the journal of the Association of European Psychiatrists 2006;21(6):419-26.
2006: Philip Hazell; Shuyu Zhang; Tomasz Wolańczyk; Joanne Barton; Mats Johnson; Alessandro Zuddas; Marina Danckaerts; Andrula Ladikos; David Benn; Roni Yoran-Hegesh; Pal Zeiner; David Michelson
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
European child & adolescent psychiatry 2006;15(2):105-10.
2006: Jan K Buitelaar; Joanne Barton; Marina Danckaerts; Edgar Friedrichs; Christopher Gillberg; Philip Hazell; Hans Hellemans; Mats Johnson; Luuk J Kalverdijk; Gabriele Masi; David Michelson; Olivier Revol; Javier San Sebastian; Shuyu Zhang; Alessandro Zuddas
A comparison of North American versus non-North American ADHD study populations.
European child & adolescent psychiatry 2006;15(3):177-81.
2006: Alessandra Frigerio; Laura Vanzin; Valentina Pastore; Maria Nobile; Roberto Giorda; Cecilia Marino; Massimo Molteni; Paola Rucci; Massimo Ammaniti; Loredana Lucarelli; Carlo Lenti; Mauro Walder; Andrea Martinuzzi; Ombretta Carlet; Filippo Muratori; Annarita Milone; Alessandro Zuddas; Pina Cavolina; Franco Nardocci; Andrea Tullini; Pierluigi Morosini; Gabriella Polidori; Giovanni de Girolamo
The Italian preadolescent mental health project (PrISMA): rationale and methods.
International journal of methods in psychiatric research 2006;15(1):22-35.
2005: Robert D Oades; Adolfo G Sadile; Terje Sagvolden; Davide Viggiano; Alessandro Zuddas; Paola Devoto; Heidi Aase; Espen Borgå Johansen; Lucia A Ruocco; Vivienne Ann Russell
The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles.
Developmental science 2005;8(2):122-31.
2004: Jan K Buitelaar; Marina Danckaerts; Christopher Gillberg; Alessandro Zuddas; Katja Becker; Manuel Bouvard; Jenny Fagan; Julia Gadoros; Valerie Harpin; Philip Hazell; Mats Johnson; Tally Lerman-Sagie; Cesar A Soutullo; Tomasz Wolanczyk; Pal Zeiner; Daniel S Fouche; Judith Krikke-Workel; Shuyu Zhang; David Michelson
A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD.
European child & adolescent psychiatry 2004;13(4):249-57.
2004: Pietro Panei; Romano Arcieri; STEFANO VELLA; Maurizio Bonati; Nello Martini; Alessandro Zuddas
Italian attention-deficit/hyperactivity disorder registry.
Pediatrics 2004;114(2):514.
2004: David Michelson; Jan K Buitelaar; Marina Danckaerts; Christopher Gillberg; Thomas J Spencer; Alessandro Zuddas; Douglas E Faries; Shuyu Zhang; Joseph Biederman
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.
Journal of the American Academy of Child and Adolescent Psychiatry 2004;43(7):896-904.
2004: Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan K Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund J S Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
European clinical guidelines for hyperkinetic disorder -- first upgrade.
European child & adolescent psychiatry 2004;13 Suppl 1():I7-30.
2004: Adriana Di Martino; Gianluigi Melis; Carlo Cianchetti; Alessandro Zuddas
Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study.
Journal of child and adolescent psychopharmacology 2004;14(2):207-18.
2002: Vanessa Lilliu; Carla Perrone-Capano; Roberto Pernas-Alonso; Ramon Diaz Trelles; G Luca Colucci d'Amato; Alessandro Zuddas; Umberto di Porzio
Ontogeny of kainate receptor gene expression in the developing rat midbrain and striatum.
Brain research. Molecular brain research 2002;104(1):1-10.
2002: Alessandro Zuddas; Cristina Mancosu; Vanessa Lilliu; Giuseppe Sorrentino; Umberto di Porzio; Carlo Cianchetti
6R-Tetrahydrobiopterin induces dopamine synthesis in a human neuroblastoma cell line, LA-N-1. A cellular model of DOPA-responsive dystonia.
Brain research 2002;943(2):257-62.
2001: Vanessa Lilliu; Roberto Pernas-Alonso; R D Trelles; Umberto di Porzio; Alessandro Zuddas; Carla Perrone-Capano
Ontogeny of AMPA receptor gene expression in the developing rat midbrain and striatum.
Brain research. Molecular brain research 2001;96(1-2):133-41.
2000: Alessandro Zuddas; Adriana Di Martino; P Muglia; Carlo Cianchetti
Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation.
Journal of child and adolescent psychopharmacology 2000;10(2):79-90.
2000: Alessandro Zuddas; B Ancilletta; P Muglia; Carlo Cianchetti
Attention-deficit/hyperactivity disorder: a neuropsychiatric disorder with childhood onset.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2000;4(2):53-62.
1999: Carlo Cianchetti; Alessandro Zuddas; A P Randazzo; L Perra; Maria Giovanna Marrosu
Lamotrigine adjunctive therapy in painful phenomena in MS: preliminary observations.
Neurology 1999;53(2):433.
1999: Giuseppe Sorrentino; M R Monsurrò; Guido Pettinato; Roberta Vanni; Alessandro Zuddas; Umberto di Porzio; Vincenzo Bonavita
Establishment and characterization of a human neuroectodermal cell line (TB) from a cerebrospinal fluid specimen.
Brain research 1999;827(1-2):205-9.
1998: Carlo Cianchetti; Alessandro Zuddas; F Marchei
High dose intravenous methylprednisolone in cluster headache.
Journal of neurology, neurosurgery, and psychiatry 1998;64(3):418.
1998: Carlo Cianchetti; Maria Giovanna Marrosu; Francesco Muntoni; A Fratta; Alessandro Zuddas
Intraventricular alpha-interferon in subacute sclerosing panencephalitis.
Neurology 1998;50(1):315-6.
1996: Alessandro Zuddas; M Pintor; N DeMontis; M Giovanna Marrosu; Carlo Cianchetti
Continuous infusion of apomorphine improves torsion dystonia in a boy unresponsive to other dopaminergic drugs.
Journal of child neurology 1996;11(4):343-5.
1996: Alessandro Zuddas; M Pintor; Carlo Cianchetti
Risperidone for negative symptoms.
Journal of the American Academy of Child and Adolescent Psychiatry 1996;35(7):838-9.
1996: Alessandro Zuddas; M G Ledda; A Fratta; P Muglia; Carlo Cianchetti
Clinical effects of clozapine on autistic disorder.
The American journal of psychiatry 1996;153(5):738.
1996: Alessandro Zuddas; Carlo Cianchetti
Efficacy of risperidone in idiopathic segmental dystonia.
Lancet 1996;347(8994):127-8.
1994: Alessandro Zuddas; F Fascetti; Giovanni U Corsini; Paola Piccardi
In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
Experimental neurology 1994;127(1):54-61.
1992: Alessandro Zuddas; G Oberto; Francesca Vaglini; F Fascetti; Francesco Fornai; Giovanni U Corsini
MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.
Journal of neurochemistry 1992;59(2):733-9.
1992: Alessandro Zuddas; Francesca Vaglini; Francesco Fornai; F Fascetti; Antonio Saginario; Giovanni U Corsini
Pharmacologic modulation of MPTP toxicity: MK 801 in prevention of dopaminergic cell death in monkeys and mice.
Annals of the New York Academy of Sciences 1992;648():268-71.
1992: Umberto di Porzio; Alessandro Zuddas
Embryonic dopaminergic neuron transplants in MPTP lesioned mouse striatum.
Neurochemistry international 1992;20 Suppl():309S-320S.
1992: Alessandro Zuddas; Francesca Vaglini; Francesco Fornai; Giovanni U Corsini
Selective lesion of the nigrostriatal dopaminergic pathway by MPTP and acetaldehyde or diethyldithiocarbamate.
Neurochemistry international 1992;20 Suppl():287S-293S.
1992: Alessandro Zuddas; Francesca Vaglini; Francesco Fornai; Giovanni U Corsini
Pharmacological modulation of development and plasticity in nigro striatal dopaminergic neurons.
Pharmacological research : the official journal of the Italian Pharmacological Society 1992;25 Suppl 1():29-30.
1991: Krystof Bankiewicz; Edward H Oldfield; R J Plunkett; W H Schuette; D G Cogan; N Hogan; Alessandro Zuddas; Irwin J Kopin
Apparent unilateral visual neglect in MPTP-hemiparkinsonian monkeys is due to delayed initiation of motion.
Brain research 1991;541(1):98-102.
1991: M L Fiszman; Alessandro Zuddas; M I Masana; Jeffery L Barker; Umberto di Porzio
Dopamine synthesis precedes dopamine uptake in embryonic rat mesencephalic neurons.
Journal of neurochemistry 1991;56(2):392-9.
1990: Alessandro Zuddas; Francesca Vaglini; Francesco Fornai; Giovanni U Corsini
Embryonic neural grafts induce recovery in mice with permanent striatal lesion.
Pharmacological research : the official journal of the Italian Pharmacological Society 1990;22 Suppl 1():3-4.
1990: Umberto di Porzio; Alessandro Zuddas; D B Cosenza-Murphy; Jeffery L Barker
Early appearance of tyrosine hydroxylase immunoreactive cells in the mesencephalon of mouse embryos.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 1990;8(5):523-32.
1989: Alessandro Zuddas; Giovanni U Corsini; S Schinelli; Jeffery L Barker; Irwin J Kopin; Umberto di Porzio
Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum.
Brain research 1989;501(1):11-22.
1989: Alessandro Zuddas; Giovanni U Corsini; S Schinelli; J N Johannessen; Umberto di Porzio; Irwin J Kopin
MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra.
Brain research 1989;501(1):1-10.
1988: Giovanni U Corsini; Alberto Bocchetta; Alessandro Zuddas; Paola Piccardi; Maria Del Zompo
Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivo.
Biochemical pharmacology 1988;37(21):4163-9.
1988: Alberto Bocchetta; Paola Piccardi; Alessandro Zuddas; F Bernardi; M D Zompo; Giovanni U Corsini
MPTP-induced parkinsonism. Recent studies on the mechanism of toxicity.
Functional neurology 1988;3(4):439-47.
1988: S Schinelli; Alessandro Zuddas; Irwin J Kopin; Jeffery L Barker; Umberto di Porzio
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
Journal of neurochemistry 1988;50(6):1900-7.
1987: Giovanni U Corsini; Alessandro Zuddas; Ubaldo Bonuccelli; S Schinelli; Irwin J Kopin
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde.
Life sciences 1987;40(9):827-32.
1986: F Marrosu; Alessandro Zuddas
Epileptic EEG pattern in alcoholic women.
Functional neurology 1986;1(3):297-8.
1985: Alessandro Zuddas; S Mulas; Maria Del Zompo; G U Corsini
Cluster headache: clinical efficacy of lithium salts in a haemodialysis treated patient.
Cephalalgia : an international journal of headache 1985;5(2):95-8.
1985: Maria Del Zompo; S Pintus; Alessandro Zuddas; Giovanni U Corsini
Deprenyl selectively inhibits [3H]MPTP binding sites in monkey brain.
European journal of pharmacology 1985;107(2):285-6.